Inventor · disambiguated record
Hyo Min Ahn
Also filed as: AHN HYO MIN
1 granted patent·5 pending applications·0 citations·filing 2016–2024
14Inventor score
Top patents by PatentIndex Score
6 records- 0170US2025082702A1Anticancer composition comprising recombinant adenovirus expressing degradation factor for extracellular matrixGENEMEDICINE CO LTD·Filed 2024·Application pending·0 cites
- 0261US11364272B2Anticancer composition comprising tumor-specific oncolytic adenovirus and immune checkpoint inhibitorGENEMEDICINE CO LTD·Filed 2019·Granted Jun 21, 2022·0 cites·11 claims
- 0358US2022347242A1Anticancer composition comprising tumor-specific oncolytic adenovirus and immune checkpoint inhibitorGENEMEDICINE CO LTD·Filed 2022·Application pending·0 cites
- 0457US2022233718A1Antitumor immunity enhancing composition containing adenovirus simultaneously expressing il-12 and shvegfGENEMEDICINE CO LTD·Filed 2022·Application pending·0 cites
- 0553US2019358277A1Anticancer composition comprising recombinant adenovirus expressing degradation factor for extracellular matrixGENEMEDICINE CO LTD·Filed 2019·Application pending·0 cites
- 0642US2018369417A1Antitumor immunity enhancing composition containing adenovirus simultaneously expressing il-12 and shvegfINDUSTRY UNIV COORPERATION FOUNDATION HANYANG UNIV·Filed 2016·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Hyo Min Ahn files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →